Results 61 to 70 of about 72,883 (309)
The role of extracellular vesicles in cutaneous remodeling and hair follicle dynamics [PDF]
, 2019 Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are cell-derived membranous structures that were originally catalogued as a way of releasing cellular waste products.
Carrasco, Elisa +2 more
core +2 more sources
Alopecia areata after ChAdOx1 nCoV‐19 vaccine (Oxford/AstraZeneca): a potential triggering factor?
Journal of Cosmetic Dermatology, 2021 Dear Editor, Many dermatologists have been occupied with recording cutaneous associations with SARSCoV2 infection, and there are some reports about cutaneous side effects of its vaccines.1 Only a few reports described a possible association between AA ...
Reham Essam +4 more
semanticscholar +1 more source
SAGE Open Medical Case Reports, 2023 Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Selena Osman, Danya Traboulsi
doaj +1 more source
A mixed methods survey of social anxiety, anxiety, depression and wig use in alopecia [PDF]
, 2017 Objectives This study aimed to examine levels of social anxiety, anxiety and depression reported by people with alopecia as a result of a dermatological condition and associations with wig use.
Bewley +29 more
core +1 more source
Hair follicle immune privilege and its collapse in alopecia areata
Experimental Dermatology, 2020 Anagen stage hair follicles (HFs) exhibit “immune privilege (IP)” from the level of the bulge downwards to the bulb. Both passive and active IP mechanisms protect HFs from physiologically undesired immune responses and limit immune surveillance.
M. Bertolini +4 more
semanticscholar +1 more source
Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
International Journal of Molecular Sciences, 2021 Alopecia areata (AA) is regarded as a tissue-specific and cell-mediated autoimmune disorder. Regarding the cytokine balance, AA has been considered a type 1 inflammatory disease.
R. Kageyama +7 more
semanticscholar +1 more source
Anais Brasileiros de Dermatologia, 2012 Diffuse alopecia is mainly caused by telogen effluvium, diffuse androgenetic alopecia (femalepattern hair loss) and diffuse alopecia areata. Differential diagnosis between the three disorders may be difficult in several occasions.
Betina Werner, Fabiane Mulinari-Brenner
doaj +1 more source
Epidemiology of alopecia areata in Baqubah city/Diyala-Iraq
Diyala Journal of Medicine, 2023 Background: Alopecia areata is a disease scalp and body hair leading to patches of non-scoring alopecia which is heterogeyous ,it is unown as autommutte disease, there is no prevention & hard cure.
Rihab Shihab Ahmed, +3 more
doaj +1 more source
Retrospective review of diphencyprone in the treatment of alopecia areata [PDF]
, 2015 Contact immunotherapy with diphencyprone (DCP) is used to treat alopecia areata (AA). Its reported efficacy is variable, and individual response cannot be predicted.
Holmes, S., Lamb, R. C., Young, D.
core +1 more source
Central European Journal of Immunology, 2020 Alopecia areata is a condition that affects hair follicles and leads to hair loss ranging from small well-defined patches to complete loss of all body hair. Despite its high incidence, the pathobiology is not fully understood, and no single concept could be universally accepted. Alopecia areata is mostly considered to be an autoimmune disease, in which
Lidia Rudnicka +2 more
openaire +2 more sources